These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9788258)

  • 41. Expression and tissue distribution of hepatocyte growth factor (HGF) and its receptor (c-Met) in alpacas (Vicugna pacos) skins associated with white and brown coat colors.
    Yu X; He X; Jiang J; He J; Fan R; Wang H; Geng J; Dong C
    Acta Histochem; 2015 Sep; 117(7):624-8. PubMed ID: 26099836
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amphiregulin and epidermal growth factor receptor expression in human malignant fibrous histiocytoma of soft tissues.
    Yamamoto T; Fujita I; Akisue T; Marui T; Nakatani T; Kawamoto T; Hitora T; Nagira K; Matsumoto K; Kurosaka M
    Anticancer Res; 2004; 24(2C):1307-10. PubMed ID: 15154665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats.
    Ueda H; Nakamura T; Matsumoto K; Sawa Y; Matsuda H; Nakamura T
    Cardiovasc Res; 2001 Jul; 51(1):41-50. PubMed ID: 11399246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatocyte growth factor and c-MET are expressed in rat prepuberal testis.
    Catizone A; Ricci G; Arista V; Innocenzi A; Galdieri M
    Endocrinology; 1999 Jul; 140(7):3106-13. PubMed ID: 10385403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
    Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The expression of Met/hepatocyte growth factor receptor gene in giant cell tumors of bone and other benign musculoskeletal tumors.
    Ferracini R; Scotlandi K; Cagliero E; Acquarone F; Olivero M; Wunder J; Baldini N
    J Cell Physiol; 2000 Aug; 184(2):191-6. PubMed ID: 10867643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
    Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
    Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer.
    Kwon Y; Godwin AK
    Reprod Sci; 2017 Apr; 24(4):494-501. PubMed ID: 27170665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional expression of HGF and its receptor in human colorectal cancer.
    Otte JM; Schmitz F; Kiehne K; Stechele HU; Banasiewicz T; Krokowicz P; Nakamura T; Fölsch UR; Herzig K
    Digestion; 2000; 61(4):237-46. PubMed ID: 10878450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
    Mineo R; Costantino A; Frasca F; Sciacca L; Russo S; Vigneri R; Belfiore A
    Endocrinology; 2004 Sep; 145(9):4355-65. PubMed ID: 15192042
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors.
    Rao UN; Sonmez-Alpan E; Michalopoulos GK
    Hum Pathol; 1997 Sep; 28(9):1066-70. PubMed ID: 9308731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
    Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.
    Dobashi Y; Suzuki S; Sugawara H; Ooi A
    Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunolocalization of hepatocyte growth factor and its receptor (c-Met) during mouse liver development.
    Ishikawa KS; Masui T; Ishikawa K; Shiojiri N
    Histochem Cell Biol; 2001 Nov; 116(5):453-62. PubMed ID: 11735009
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histiocyte-like cells expressing factor XIIIa do not belong to the neoplastic cell population in malignant fibrous histiocytoma.
    Szollosi Z; Nemeth T; Egervari K; Nemes Z
    Pathol Res Pract; 2005; 201(5):369-77. PubMed ID: 16047946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comprehensive molecular analyses of lung adenocarcinoma with regard to the epidermal growth factor receptor, K-ras, MET, and hepatocyte growth factor status.
    Onitsuka T; Uramoto H; Ono K; Takenoyama M; Hanagiri T; Oyama T; Izumi H; Kohno K; Yasumoto K
    J Thorac Oncol; 2010 May; 5(5):591-6. PubMed ID: 20150826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of hepatocyte growth factor and its receptor c-Met in nasal polyps.
    Rho HS; Lee SH; Lee HM; Lee SH; Jung HH; Choi J; Park MK; Kang SM
    Arch Otolaryngol Head Neck Surg; 2006 Sep; 132(9):985-9. PubMed ID: 16982975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PET of c-Met in Cancer with ⁶⁴Cu-Labeled Hepatocyte Growth Factor.
    Luo H; Hong H; Slater MR; Graves SA; Shi S; Yang Y; Nickles RJ; Fan F; Cai W
    J Nucl Med; 2015 May; 56(5):758-63. PubMed ID: 25840981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
    Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P
    Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatocyte growth factor and c-Met immunoreactivity are associated with metastasis in high grade salivary gland carcinoma.
    Tsukinoki K; Yasuda M; Mori Y; Asano S; Naito H; Ota Y; Osamura RY; Watanabe Y
    Oncol Rep; 2004 Nov; 12(5):1017-21. PubMed ID: 15492787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.